Rare disease diagnosis boost: new study eyes key clues in ASMD patients
NCT ID NCT07274826
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at symptoms and lab tests to help doctors better diagnose acid sphingomyelinase deficiency (ASMD), also known as Niemann-Pick disease, a rare genetic disorder. Researchers will track changes in spleen and liver size using ultrasound over 12 months in 7 patients. The goal is to improve how this condition is identified and monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACID SPHINGOMYELINASE DEFICIENCY (ASMD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sohag University Hospital
Sohag, Egypt